Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.

Research output: Contribution to journalReview article

Abstract

Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 ("high-intensity" warfarin).

Original languageEnglish (US)
Pages (from-to)370-373
Number of pages4
JournalCurrent rheumatology reports
Volume5
Issue number5
DOIs
StatePublished - Oct 2003

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.'. Together they form a unique fingerprint.

  • Cite this